Retour aux projets

18171.1 PFLS-LS

18171.1 PFLS-LS

Résumé

Lung-on-Chip for Pulmonary Fibrosis Compound Testing

Textes supplémentaires

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease with poor prognosis. Clinical evidence suggests that the mechanical strain induced by the respiration plays a key role in the progression of the disease. In contrast to current in-vivo and in-vitro models that poorly mimic key processes that take place in IPF, an advanced in-vitro model of the lung will be developed to test anti-fibrotic compounds.

Participants

Olivier Guenat

Wirtschaftspartner

olivier.guenat@alveolix.com

AlveoliX AG CHE-475.985.759 Olivier Guenat Murtenstrasse 50 3008 Bern BE CH

Olivier Guenat

Kontaktperson

olivier.guenat@artorg.unibe.ch

Universität Bern ARTORG Center Olivier Guenat Murtenstrasse 50 3008 Bern BE CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2015-12-31
Date de fin
2017-10-31
Coûts totaux approuvés
CHF 317552.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%